Predictors of outcome in chronic thromboembolic pulmonary hypertension
- PMID: 17420352
- DOI: 10.1161/CIRCULATIONAHA.106.661041
Predictors of outcome in chronic thromboembolic pulmonary hypertension
Abstract
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by intraluminal thrombus organization and fibrous obliteration of pulmonary arteries. Recently, associated medical conditions such as splenectomy, ventriculoatrial shunt for the treatment of hydrocephalus, permanent central intravenous lines, inflammatory bowel disease, and osteomyelitis were found to be associated with the development of CTEPH. The study aim was to define the impact of these novel risk factors on survival.
Methods and results: Between January 1992 and December 2006, 181 patients diagnosed with CTEPH were tracked with the use of our center's customized computer database. A Cox regression model was used to examine relations between survival and associated medical conditions, age, sex, hemodynamic parameters, modified New York Heart Association functional class at diagnosis, CTEPH type, pulmonary endarterectomy, and anti-cardiolipin antibodies/lupus anticoagulant. During a median observation time of 22.1 (range, 0.03 to 152) months, the clinical end point of cardiovascular death or lung transplantation occurred in 48 cases (27%). Pulmonary endarterectomy (hazard ratio, 0.14; 95% CI, 0.05 to 0.41; P=0.0003), associated medical conditions (hazard ratio, 3.17; 95% CI, 1.70 to 5.92; P=0.0003), and pulmonary vascular resistance (hazard ratio, 1.02; 95% CI, 1.00 to 1.04; P=0.04) were predictors of survival. Thirty-day postoperative mortality (24% versus 9%) and the incidence of postoperative pulmonary hypertension (92% versus 20%) were substantially higher in patients with associated medical conditions.
Conclusions: CTEPH-predisposing medical conditions, such as splenectomy, permanent central intravenous lines, and certain inflammatory disorders, predict poor survival in CTEPH.
Similar articles
-
Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.J Heart Lung Transplant. 2007 Apr;26(4):357-62. doi: 10.1016/j.healun.2006.12.014. J Heart Lung Transplant. 2007. PMID: 17403477
-
Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience.Eur J Cardiothorac Surg. 2009 Jun;35(6):947-52; discussion 952. doi: 10.1016/j.ejcts.2009.01.023. Epub 2009 Mar 9. Eur J Cardiothorac Surg. 2009. PMID: 19272789
-
Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.J Thorac Cardiovasc Surg. 2007 Feb;133(2):510-6. doi: 10.1016/j.jtcvs.2006.10.020. J Thorac Cardiovasc Surg. 2007. PMID: 17258590
-
[Surgical treatment of chronic thromboembolic pulmonary hypertension with pulmonary endarterectomy].G Ital Cardiol (Rome). 2006 Jul;7(7):454-63. G Ital Cardiol (Rome). 2006. PMID: 16977785 Review. Italian.
-
[Chronic thromboembolic pulmonary hypertension (CTEPH)].Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S206-8. doi: 10.1055/s-0028-1091240. Epub 2008 Sep 23. Dtsch Med Wochenschr. 2008. PMID: 18814098 Review. German.
Cited by
-
Clinical worsening during long-term follow-up in inoperable chronic thromboembolic pulmonary hypertension.Lung. 2012 Apr;190(2):161-7. doi: 10.1007/s00408-011-9350-z. Epub 2011 Dec 8. Lung. 2012. PMID: 22160210
-
Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.Can Respir J. 2010 Nov-Dec;17(6):301-34. doi: 10.1155/2010/704258. Can Respir J. 2010. PMID: 21165353 Free PMC article.
-
Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4):205-212. doi: 10.14797/mdcj-12-4-205. Methodist Debakey Cardiovasc J. 2016. PMID: 28289495 Free PMC article. Review.
-
Extracorporeal Mechanical Circulatory Support after Pulmonary Thromboendarterectomy: Experience of One Center.Ann Thorac Cardiovasc Surg. 2024;30(1):24-00070. doi: 10.5761/atcs.oa.24-00070. Ann Thorac Cardiovasc Surg. 2024. PMID: 39111866 Free PMC article.
-
Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan.BMC Pulm Med. 2022 Apr 8;22(1):138. doi: 10.1186/s12890-022-01932-0. BMC Pulm Med. 2022. PMID: 35395844 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical